J Biol Chem, Vol. 273, Issue 25, 15429-15434, June 19, 1998

Molecular Mechanism of Human CD38 Gene Expression by Retinoic Acid
IDENTIFICATION OF RETINOIC ACID RESPONSE ELEMENT IN THE FIRST INTRON

Hiroyuki Kishimoto, Shin-ichi Hoshino, Makoto Ohori, Kenji Kontani, Hiroshi Nishina, Miyuki Suzawa^§, Shigeaki Kato^§, and Toshiaki Katada

From the  Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences and the ^§ Institute of Molecular and Cellular Bioscience, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan

CD38 is a nonlineage-restricted type II transmembrane glycoprotein possessing ecto-NAD⁺ glycohydrolase activity. Because of its unique expression pattern in lymphocyte differentiation, it appears to function as an immunoregulatory molecule. We previously reported that CD38 was specifically induced by all-trans-retinoic acid (RA) in human promyelocytic leukemia HL-60 cells. Here we studied the molecular mechanism of the RA-dependent induction of human CD38. The expression of CD38 mRNA by RA appeared to be caused by the transcriptional stimulation of the gene, since it was blocked by an RNA synthesis inhibitor, but not by a protein synthesis inhibitor. In search of the RA response element (RARE) possibly present in human CD38 gene promoter, we isolated and sequenced the genomic DNA covering the 5'-flanking region, exon 1, and partial intron 1. Transient transfection experiments revealed that the responsiveness to RA was conferred through an RARE consisting of two direct repeat TGACCT-like hexamer motifs with a 5-nucleotide spacer, which was located in the first intron rather than the 5'-flanking region of the CD38 gene. This RARE interacted with heterodimer composed of RA receptor and retinoid X receptor in vitro. Thus, the RA-induced expression of the human CD38 gene was demonstrated to be mediated through the RARE located in the first intron.